Terkko Navigator / Leinonen, E(sa)

A Survey of Electroconvulsive Therapy in Finland.

Time to care? Temporal variations of agency of the Finnish adult foster carers.

Implementing physical exercise and music interventions for patients suffering from dementia on an acute psychogeriatric inpatient ward.

Umbilical artery pH and base excess at birth are poor predictors of neurodevelopmental morbidity in early childhood.

Assessment of alcohol consumption in depression follow-up using self-reports and blood measures including inflammatory biomarkers.

Status of inflammation and alcohol use in a 6-month follow-up study of patients with major depressive disorder.

The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression.

Outcome of neuropsychiatric symptoms and daily functioning of patients with dementia treated on an acute psychogeriatric ward.

Successful Curriculum Change in Health Management and Leadership Studies for the Specialist Training Programs in Medicine in Finland.

Reversible psychiatric adverse effects related to deep brain stimulation of the anterior thalamus in patients with refractory epilepsy.

Effect of electroconvulsive therapy on brain-derived neurotrophic factor levels in patients with major depressive disorder.

Blended learning and an exploration of student expectations on a Master's prosthodontics programme with reassessment at five years.

Outbreak of multiple strains of non-O157 Shiga toxin-producing and enteropathogenic Escherichia coli associated with rocket salad, Finland, autumn 2016.

Behavioral activation versus treatment as usual in naturalistic sample of psychiatric patients with depressive symptoms: a benchmark controlled trial.

Temperament clusters associate with anxiety disorder comorbidity in depression.

Temperament and character profiles are associated with depression outcome in psychiatric secondary care patients with harmful drinking.

Low tumor necrosis factor-α levels predict symptom reduction during electroconvulsive therapy in major depressive disorder.

The effects of adiposity and alcohol use disorder on adipokines and biomarkers of inflammation in depressed patients.

Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving Clozapine.

Assessing social-pragmatic inferencing skills in children with autism spectrum disorder.

Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder.

BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depression.

Identification of NCAN as a candidate gene for developmental dyslexia.

The State of Opioid Agonist Therapy in Canada 20 Years after Federal Oversight.

Anxiety Disorders and Temperament-an Update Review.

Histaminergic gene polymorphisms associated with sedation in clozapine-treated patients.

INSIG2 polymorphism and weight gain, dyslipidemia and serum adiponectin in Finnish patients with schizophrenia treated with clozapine.

Changes in interleukin-6 levels during electroconvulsive therapy may reflect the therapeutic response in major depression.

Association study of arcuate nucleus neuropeptide Y neuron receptor gene variation and serum NPY levels in clozapine treated patients with schizophrenia.

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.

Resistin as an inflammatory marker in patients with schizophrenia treated with clozapine.

Genome-wide association analysis reveals variants on chromosome 19 that contribute to childhood risk of chronic otitis media with effusion.

Temperament and character profiles associated with depression and treatment response in patients with or without comorbid substance abuse.

[The latest antipsychotics--novelties or reiteration of the old?].

Acute Psychogeriatric Inpatient Treatment Improves Neuropsychiatric Symptoms but Impairs the Level of Functioning in Patients with Dementia.

[Diagnosis and drug therapy of anxiety disorders in primary health care].

Psychiatric hospital admission and long-term care in patients with very-late-onset schizophrenia-like psychosis.

Predisposition to Childhood Otitis Media and Genetic Polymorphisms within the Toll-Like Receptor 4 (TLR4) Locus.

Noun Case Suffix Use by Children with Specific Language Impairment: An Examination of Finnish.

The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.

SERT and NET polymorphisms, temperament and antidepressant response.

Serotonin transporter (5-HTTLPR) and norepinephrine transporter (NET) gene polymorphisms: Susceptibility and treatment response of electroconvulsive therapy in treatment resistant depression.

FGF23 gene variation and its association with phosphate homeostasis and bone mineral density in Finnish children and adolescents.

Association study of the HTR2C, leptin and adiponectin genes and serum marker analyses in clozapine treated long-term patients with schizophrenia.

Factors associated with subjective side-effects during clozapine treatment.

Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatment.

Patients with very-late-onset schizoprhenia-like psychosis have higher mortality rates than elderly patients with earlier onset schizophrenia.

Meta-Analysis of Anxiety Disorders and Temperament.

Cytokine and adipokine alterations in patients with schizophrenia treated with clozapine.

Smoking and weight among patients using clozapine.